Mark Winderlich's most recent trade in Hookipa Pharma Inc was a trade of 250,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Mark Winderlich | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Mark Winderlich | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |